Home » Topics » Regulatory » Patents

Patents
RSS

Shanghai Pharmaceuticals Holding identifies new EGFR/ERBB2 inhibitors

Sep. 18, 2017

Ontario Institute for Cancer Research discovers WDR5-MLL protein binding inhibitors

Sep. 18, 2017

Roche describes novel cathepsin S inhibitors

Sep. 18, 2017

Massachusetts General Hospital, Dana-Farber and Harvard patent antifungal compounds

Sep. 18, 2017

Da Volterra and Bioaster present beta-lactamase variants

Sep. 15, 2017

Bayer Pharma divulges BRD4 inhibitors for cancer

Sep. 15, 2017

Alios BioPharma presents FXR agonists for NASH

Sep. 15, 2017

RET inhibitors disclosed in GlaxoSmithKline patent

Sep. 15, 2017

Shenzhen Targetrx Biotechnology discloses IDO inhibitors

Sep. 15, 2017

NovoBiotic Pharmaceuticals patents novel macrocyclic antibiotics

Sep. 15, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...